LIFE SCIENCE ADVISORY
RE-DESIGN WHAT MATTERS.
Re-invent the patient journey. Protect profitability.
Life sciences commercialization is no longer about a single function. Patient access, payer dynamics, channel strategy, specialty pharmacy, data, affordability, and gross-to-net economics are deeply connected.
Patrick R. Coyle brings these disciplines together to help life sciences organizations make better commercialization decisions, improve access, and protect sustainable profitability.
Patients + Profitability™
Better patient outcomes and stronger financial outcomes should not be competing objectives.
The opportunity is to redesign the commercial ecosystem so that access, affordability, channels, payer strategy, data, and financial performance work together.
One connected ecosystem. One strategic view. Better decisions.
Prior Authorization
Understand how authorization requirements affect access, time to therapy, and commercial performance.
Provider Workflows
Align provider processes and operational realities with the patient journey.
Affordability & Copay Programs
Evaluate the financial and access implications of affordability programs and patient support strategies.
Patient Support Programs
Connect support services to measurable patient access and commercial outcomes.
Specialty Pharmacies
Understand specialty distribution and pharmacy dynamics that influence product access and pull-through.
Data & Analytics
Turn fragmented commercial and financial data into actionable insights.
Channel Partners
Improve alignment across the organizations influencing the path to patient.
Payer Policy & Access
Evaluate payer requirements, restrictions, and policy dynamics that shape access and revenue.
From Commercial Complexity to Strategic Clarity
Every decision across the commercialization ecosystem can create downstream consequences.
A change in payer policy can affect access.
A change in access can affect pull-through.
A change in channel strategy can affect gross-to-net.
A change in patient support can affect both experience and economics.
The goal is not to optimize one component in isolation.
The goal is to understand the system — and redesign what matters.
Reduce Leakage
Identify financial and operational leakage across the commercialization journey.
Align Channels
Connect stakeholders, channels, and commercial objectives around a common strategy.
Improve Access
Strengthen the pathway between product, provider, payer, and patient.
Protect Profitability
Build commercial strategies that support sustainable net revenue and long-term value.
Commercialization Strategy Built for Complexity
Whether preparing for a first launch, optimizing an established brand, or navigating a complex specialty or rare-disease market, commercialization requires more than a launch plan.
It requires an integrated understanding of the market, financial model, payer environment, access strategy, channels, and operational requirements.
One Integrated Launch Plan
Our commercialization approach brings the critical pieces together:
- Market & competitive assessment
- Strategic launch planning
- Financial & GTN modeling
- Payer & access strategy
- Brand & commercial planning
- Integrated launch planning
COMMERCIALIZATION ADVISORY
Your Launch. Our Expertise. Real Impact.
From strategy to execution, commercialization requires decisions that connect market opportunity with financial reality.
The advisory approach brings together commercial strategy, financial modeling, market access, payer dynamics, and execution planning into one integrated view.
Any therapeutic area.
Any market.
Any complexity.
One integrated launch plan.
Built for Life Sciences at Critical Moments
The most consequential decisions often happen before, during, and immediately after commercialization.
Biotech & Emerging Pharma
Build the commercial and financial foundation required to move from innovation to market.
Specialty & Rare Disease
Navigate complex access, distribution, patient support, and payer environments.
New Product Commercialization
Create an integrated launch strategy that connects market opportunity with execution.
Established Brands
Identify opportunities to improve commercial performance, access, channel effectiveness, and profitability.
Physician-Administered Products
Evaluate the commercial, payer, reimbursement, and financial dynamics influencing adoption.
Complex Market Environments
Bring structure and strategic clarity to fragmented or rapidly changing commercialization ecosystems.
Where Strategy Meets Commercial Reality
The work focuses on the interconnected decisions that determine whether a life sciences product can successfully reach patients while creating sustainable economic value.
Market & Competitive Strategy
Understand the market, competitive environment, customer dynamics, and commercial opportunity.
Market Access & Payer Strategy
Evaluate payer requirements, access barriers, reimbursement dynamics, and their financial implications.
Gross-to-Net & Financial Modeling
Build decision-ready models that connect commercial assumptions with revenue and profitability.
Channel & Distribution Strategy
Assess channel structures, specialty distribution, pharmacy dynamics, and pull-through.
Patient Access & Support Economics
Understand the financial and operational impact of patient support, affordability, and access programs.
Commercial Launch Strategy
Translate strategy into an integrated launch roadmap with clear priorities, ownership, and measurable outcomes.
An Integrated Approach to Commercialization
Assess
Understand the current market, business model, financial structure, payer environment, and patient journey.
Model
Quantify the economics behind commercial assumptions, access strategies, channels, and GTN.
Identify
Surface gaps, leakage, risks, opportunities, and areas where the current model is limiting performance.
Design
Develop an integrated strategy connecting patient access, commercial execution, and financial outcomes.
Execute
Translate recommendations into practical actions, governance, and measurable priorities.
Optimize
Continuously evaluate performance and recalibrate as market conditions, payer dynamics, and business priorities evolve.
Strategic Expertise. Commercial Execution.
Patrick R. Coyle's life sciences advisory work sits at the intersection of strategy, commercialization, financial stewardship, and patient access.
For broader business advisory and commercialization planning, Novus Proximus Business Advisory provides an additional platform focused on redesigning the systems, strategies, and decisions that influence patients and profitability.
Patients + Profitability™
Experience Across the Life Sciences Value Chain
Patrick R. Coyle combines financial leadership, commercialization experience, strategic planning, gross-to-net expertise, and cross-functional business leadership to help organizations navigate complex life sciences decisions.
His experience spans pharmaceutical and biotechnology environments, with a focus on connecting strategy with execution and financial outcomes.
Strategic Leadership
Connect business strategy with measurable financial outcomes.
Commercialization Expertise
Navigate the complexity of launching and scaling life sciences products.
GTN & Financial Acumen
Understand the economics behind pricing, access, channels, and net revenue.
Cross-Functional Alignment
Bring finance, commercial, market access, and operational stakeholders around one strategy.
EXECUTIVE GUIDE
Before You Leave The Pharmacy™
Most patients believe receiving a prescription means the process is complete. In reality, insurance reviews, prior authorizations, affordability programs, pharmacy benefit managers, and manufacturer support programs often determine whether treatment actually begins.
This executive guide explains the hidden healthcare systems that shape access, affordability, and support—helping patients become more informed, confident, and engaged throughout their treatment journey.
Ready to Re-Design What Matters?
Whether you're preparing for a new product launch, navigating a complex market access environment, or looking for opportunities to improve commercial and financial performance, the first step is understanding where strategy, access, and profitability intersect.
Re-invent the patient journey. Protect profitability.